Crossmark

Fulvestrant 500 mg in postmenopausal patients with metastatic breast cancer: the initial clinical experience

Crossref DOI link: https://doi.org/10.1007/s12282-015-0612-0

Published Online: 2015-04-21

Published Print: 2016-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ishida, Naoko

Araki, Kazuhiro

Sakai, Takehiko

Kobayashi, Kokoro

Kobayashi, Takayuki

Fukada, Ippei

Hosoda, Mitsuchika

Yamamoto, Mitsugu

Ichinokawa, Kazuomi

Takahashi, Shunji

Iwase, Takuji

Ito, Yoshinori

Yamashita, Hiroko
License Information

Text and Data Mining valid from 2015-04-21